Identification of antiviral antihistamines for COVID-19 repurposing

There is an urgent need to identify therapies that prevent SARS-CoV-2 infection and improve the outcome of COVID-19 patients. Although repurposed drugs with favorable safety profiles could have significant benefit, widely available prevention or treatment options for COVID-19 have yet to be identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Reznikov, Leah R., Norris, Michael H., Vashisht, Rohit, Bluhm, Andrew P., Li, Danmeng, Liao, Yan-Shin J., Brown, Ashley, Butte, Atul J., Ostrov, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713548/
https://www.ncbi.nlm.nih.gov/pubmed/33309272
http://dx.doi.org/10.1016/j.bbrc.2020.11.095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713548/
https://www.ncbi.nlm.nih.gov/pubmed/33309272
http://dx.doi.org/10.1016/j.bbrc.2020.11.095

Ejemplares similares